Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/27/2003WO2003082189A3 Method for producing pseudo islets
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003078580A3 Imprinting in plants to control gene expression
11/27/2003WO2003076902A3 Multiplex detection of biological materials in a sample
11/27/2003WO2003074723A3 Methods for detection of genetic disorders
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003072828A3 Fcgammariib polymorphisms detection in system lupus erythematosus
11/27/2003WO2003072045A3 Treatment and prevention of aids progression and methods of using same
11/27/2003WO2003067211A3 An improvement in a method bacterial endospore quantification using lanthanide dipicolinate luminescence
11/27/2003WO2003064691A3 Methods and means for amplifying nucleic acid
11/27/2003WO2003064676A3 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003064604A3 Translation profiling
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003061583A9 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes
11/27/2003WO2003057908A3 Methods for detecting nucleic acids while using solid phase bound primers and cleaving the products of a cyclic amplification reaction (trap release primer amplification (tramp))
11/27/2003WO2003056329A3 Use of a signal transduction complex in drug discovery processes
11/27/2003WO2003053338A3 Novel chimeric rev, tat, and nef antigens
11/27/2003WO2003051901A3 Pseudonucleotide comprising an intercalator
11/27/2003WO2003048723A3 Label-free detection of nucleic acids via surface plasmon resonance
11/27/2003WO2003048300A3 Methods of identifying cellular target molecules
11/27/2003WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing
11/27/2003WO2003046203A3 Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043978A3 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
11/27/2003WO2003042700A3 Breast cancer associated polypeptide
11/27/2003WO2003040401A3 General screening method for ligand-protein interactions
11/27/2003WO2003040397A3 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons
11/27/2003WO2003035906A3 Method for genotyping microsatellite dna markers by mass spectrometry
11/27/2003WO2003031651A3 Method of determining susceptibility to inflammatory bowel disease
11/27/2003WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003029459A3 Micro-rna molecules
11/27/2003WO2003027669A3 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof
11/27/2003WO2003027262A3 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
11/27/2003WO2003023366A3 Method and system for classifying a scenario
11/27/2003WO2003023354A3 Optical bio-disc systems for nuclear morphology based identification
11/27/2003WO2003020977A3 Nucleotide repeats assay
11/27/2003WO2003020971A3 Novel method of detecting a mutation in read phase in a coding sequence and the apparatus used to carry out same
11/27/2003WO2003018746A3 Estrogen receptor alpha variants and methods of detection thereof
11/27/2003WO2003017127A3 Method for modelling biochemical pathways
11/27/2003WO2003014390A3 Screening methods and sequences relating thereto
11/27/2003WO2003014295A3 Method and system for identifying splice variants of a gene
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder
11/27/2003WO2003010328A3 Complexity management of genomic dna
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003009100A3 Methods, apparatuses, and computer programs for verifying the integrity of a probe
11/27/2003WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/27/2003WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
11/27/2003WO2003004688A3 Method of genomic analysis
11/27/2003WO2003003810A3 Methods for detection and quantification of analytes in complex mixtures
11/27/2003WO2003003057A3 System and method for capturing multi-color fish images
11/27/2003WO2003002979A3 Multiplex decoding of array sensors with microspheres
11/27/2003WO2003001181A3 Detection of clonal t-cell receptor-gamma gene rearrangement by pcr/temporal temperature gradient gel electrophoresis (tige)
11/27/2003WO2003000929A3 Polynucleotides polypeptides and cancer
11/27/2003WO2003000927A3 Method for the determination of telomere length
11/27/2003WO2002103046A3 Happier mapping
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002094195A3 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
11/27/2003WO2002093130A3 Methods of analyzing chromosomal translocations using fluorescence in situ hybridization (fish)
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002090586A3 Analytical method and kit
11/27/2003WO2002088381A3 Method for determining gene expression
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002083941A3 Highly specific detection system for detecting nucleotide sequences coding for lambda and kappa light chains
11/27/2003WO2002083932A3 Enzymatic degradation chains
11/27/2003WO2002083930A3 Immersion sensor for measuring the concentration of an analyte with the help of an oxidase
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
11/27/2003WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
11/27/2003WO2002072865A3 Methods, kits and compositions of combination oligomers
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002068962A3 Determining cartilage degeneration and aging using bone morphogenic proteins
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002064825A3 Microelectronic array devices to perform multiplex immunoassay analysis
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002061428A8 Method of disrupting interactions between biotin and biotin-binding compounds
11/27/2003WO2002061140A9 Competitive population normalization for comparative analysis of nucleic acid samples
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002057499A3 Mdr1 variants and methods for their use
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2002010438A9 Serial analysis of transcript expression using long tags
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments.
11/27/2003US20030220279 Decreasing cell proliferation by decreasing levels of PP5
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder